Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition

NCT03275597 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Non-small Cell Lung Cancer
Non-small Cell Lung Cancer Stage IV

Interventions

DRUG: Durvalumab
DRUG: Tremelimumab
RADIATION: Stereotactic Body Radiotherapy

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]